0000880771-16-000181.txt : 20160816 0000880771-16-000181.hdr.sgml : 20160816 20160816173621 ACCESSION NUMBER: 0000880771-16-000181 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160812 FILED AS OF DATE: 20160816 DATE AS OF CHANGE: 20160816 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SCICLONE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000880771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943116852 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 950 TOWER LANE STREET 2: SUITE 900 CITY: FOSTER CITY STATE: CA ZIP: 94404-2125 BUSINESS PHONE: 650-358-3456 MAIL ADDRESS: STREET 1: 950 TOWER LANE STREET 2: SUITE 900 CITY: FOSTER CITY STATE: CA ZIP: 94404-2125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Xie Lan CENTRAL INDEX KEY: 0001555794 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19825 FILM NUMBER: 161836967 MAIL ADDRESS: STREET 1: 29F SHANGHAI TIMES SQUARE STREET 2: NO. 93 HUAI HAI ZHONG ROAD CITY: SHANGHAI STATE: F4 ZIP: 200021 4 1 certent-form4.xml PRIMARY DOCUMENT X0306 4 2016-08-12 0000880771 SCICLONE PHARMACEUTICALS INC SCLN 0001555794 Xie Lan 950 TOWER LANE, SUITE 900 FOSTER CITY CA 94404 0 1 0 0 VP Finance, China CFO Common Stock 2016-08-12 4 M 0 9333 8.83 A 9333 D Common Stock 2016-08-12 4 S 0 9333 10.3610 D 0 D Common Stock 2016-08-12 4 M 0 7500 4.52 A 7500 D Common Stock 2016-08-12 4 S 0 7500 10.361 D 0 D Common Stock 2016-08-12 4 M 0 2812 4.53 A 2812 D Common Stock 2016-08-12 4 S 0 2812 10.3610 D 0 D Common Stock 2016-08-12 4 M 0 12187 5.19 A 12187 D Common Stock 2016-08-12 4 S 0 12187 10.3610 D 0 D Common Stock 2016-08-12 4 M 0 1000 0 A 1000 D Common Stock 2016-08-12 4 S 0 1000 10.41 D 0 D Non-Qualified Stock Options (right to buy) 4.52 2016-08-12 4 M 0 7500 0 D 2024-03-14 Common Stock 7500 16667 D Non-Qualified Stock Options (right to buy) 4.53 2016-08-12 4 M 0 2812 0 D 2023-04-04 Common Stock 2812 2500 D Non-Qualified Stock Options (right to buy) 5.19 2016-08-12 4 M 0 12187 0 D 2022-08-01 Common Stock 12187 0 D Non-Qualified Stock Options (right to buy) 8.83 2016-08-12 4 M 0 9333 0 D 2025-03-16 Common Stock 9333 18667 D Restricted Stock Unit 2016-08-12 4 A 0 10000 0 A Common Stock 10000 18000 D Restricted Stock Unit 2016-08-12 4 M 0 1000 0 D Common Stock 1000 17000 D Granted under the Issuer's 2005 Equity Incentive Plan. 25% of such shares vest from one year from the date of grant and 2.0833% vests each month thereafter, provided that the Reporting Person continues to be employed by the Issuer. Granted under the Issuer's 2015 Equity Incentive Plan. Each restricted stock unit represents the contingent right to receive one share of SciClone Pharmaceuticals, Inc.'s common stock. Each RSU will vest and be settled on August 15, 2017, subject to the reporting person's continued employment, but will terminate upon the occurrence of a change in control on or before March 31, 2017. Vesting for such RSUs will occur 25% on March 16, 2016, 25% on March 16, 2017, 25% on March 16, 2018, and 25% on March 16, 2019, or on such later date thereafter as the Company's trading window opens, if it is not open on any of such dates, contingent upon the executive's continued employment. /s/ Friedhelm Blobel, Attorney-in-Fact For Lan Xie 2016-08-16